Long-term safety and efficacy of adalimumab in psoriasis: a multicentric study focused on infections (connecting study).
Conclusions: Adalimumab is effective and safe in patients affected by these important infections.
PMID: 32792888 [PubMed]
Source: Advances in Dermatology and Allergology - Category: Dermatology Tags: Postepy Dermatol Alergol Source Type: research
More News: Arthritis | Autoimmune Disease | Cardiology | Depression | Dermatology | Heart | Hepatitis | Hepatitis B | Hepatitis C | Humira | Italy Health | Pain | Pain Management | Psoriasis | Rheumatology | Skin | Study | Toxicology | Tuberculosis